NeuroSense Therapeutics Ltd.
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.65-3.4410.632.01
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-0.70$-0.34$0.11$0.58

Historical Multiples (2019 – 2023)

2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-6.39-2.77-1.91-1.25-1.05N/A-2.34
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
8.5411.890.532.49-5.71N/A1.51
Price/Cash Flow ratio
-13.47-11.28-3.10-1.85-1.26N/A-7.19
Price/Free Cash Flow ratio
-13.31-11.13-3.06-1.83-1.26N/A-7.10
Price/Earnings Growth ratio
N/A-0.020.160.050.07N/A0.10
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-0.40%-0.03%38.25%9.26%N/AN/A23.76%
Return on Assets
-128.48%-363.15%-21.82%-145.22%-318.23%N/A-192.49%
Return On Equity
-133.66%-429.28%-27.70%-199.27%539.32%N/A-228.49%
Return on Capital Employed
-134.53%-438.23%-51.56%-226.47%4257.59%N/A-244.90%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A10.96N/A
Quick Ratio
24.676.0719.416.400.8410.9315.17
Cash ratio
24.185.8218.532.050.765.4311.98
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A-8.15-21.65K-15.08KN/AN/A-10.83K
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A6.69K4.74K2.04K5.49KN/A3.39K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/A0.01N/A0.140.07
Debt Equity Ratio
N/AN/AN/A0.02N/A0.170.08
Long-term Debt to Capitalization
N/AN/AN/A0.02N/A0.020.01
Total Debt to Capitalization
N/AN/AN/A0.02N/AN/A0.01
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/A-51.60N/AN/AN/A
Company Equity Multiplier
1.041.181.261.37-1.691.171.32
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.011.011.001.00N/A1.01
Cash Flow Coverage Ratio
N/AN/AN/A-51.60N/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A